SCHEMBL23918734

SCHEMBL23918734

CCOC(=O)C1=C(O)C(=O)N(C2CCN(C(=O)OC(C)(C)C)C2)C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.43
USP30 Q70CQ3 2/20 0.41
GPR119 Q8TDV5 2/20 0.41
BTK Q06187 1/20 0.40
ADORA1 P30542 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
ALDH1A1 P00352 3/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
LMNA P02545 1/20 0.39
GAA P10253 1/20 0.39
KDM4E B2RXH2 2/20 0.38
MAPT P10636 2/20 0.38
THRB P10828 1/20 0.38
POLB P06746 1/20 0.37
GLA P06280 1/20 0.37
HPGD P15428 1/20 0.37
RECQL P46063 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24379692 0.91 ADORA1 (0.40) TP53GPR119ADORA1ALDH1A1MEN1
SCHEMBL24379670 0.82 ALDH1A1 (0.41) TP53GPR119ADORA1ALDH1A1MEN1
SCHEMBL23918539 0.80 ALDH1A1 (0.42) TP53GPR119ADORA1ALDH1A1MEN1
SCHEMBL29428234 0.79 ALDH1A1 (0.42) L3MBTL1ALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL23918399 0.78 SMN1; SMN2 (0.41) L3MBTL1ALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL23918766 0.76 ALDH1A1 (0.50) ALDH1A1MEN1KMT2AKDM4EMAPT
SCHEMBL23918388 0.76 ALDH1A1 (0.53) ALDH1A1KMT2APOLB
SCHEMBL23918744 0.76 MEN1 (0.39) TP53GPR119ADORA1ALDH1A1MEN1
SCHEMBL31257394 0.76 TP53 (0.44) TP53USP30GPR119BTKL3MBTL1
SCHEMBL30318333 0.72 GPR119 (0.44) TP53GPR119BTKADORA1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11319324-B2 Pyrazolo-pyrrolo-pyrimidine-dione derivatives as P2X3 inhibitors BAYER AKTIENGESELLSCHAFT (DE) 2022-05-03 US disclosed
US-20210317128-A1 NOVEL PYRAZOLO-PYRROLO-PYRIMIDINE-DIONE DERIVATIVES AS P2X3 INHIBITORS BAYER AKTIENGESELLSCHAFT (DE) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11319324-B2 Pyrazolo-pyrrolo-pyrimidine-dione derivatives as P2X3 inhibitors P2RX3, P2RX1, P2RX5 TP53 2109/4885USP30 2413/4885GPR119 625/4885
US-20210317128-A1 NOVEL PYRAZOLO-PYRROLO-PYRIMIDINE-DIONE DERIVATIVES AS P2X3 INHIBITORS P2RX3, P2RX1, P2RX5 TP53 2098/4885USP30 2112/4885GPR119 607/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.